Georg Griesinger is Professor at Luebeck University and head of the Department of Gynecological Endocrinology and Reproductive Medicine, University Hospital of Schleswig-Holstein, Luebeck, Germany.
An Austrian native born in Salzburg, he studied medicine at the University of Vienna. His MD thesis research was carried out in the laboratory of Professor Martin Knöfler and he also obtained an MSc degree in prenatal genetics and fetal medicine at University College London under the guidance of Professor Joyce Harper. From 2003 onward, he trained in obstetrics and gynecology and did his sub-specialization in reproductive endocrinology in the group led by Professor Klaus Diedrich in Luebeck, with whom he had a long-standing and successful academic collaboration. He obtained his venia legendi (the German equivalent to a PhD degree) in 2007 and was appointed full professor (2010) and tenure professor (2016) at the University of Luebeck.
Professor Greisinger's fields of expertise are foremost in reproductive endocrinology and clinical trials. He has worked extensively on ovarian stimulation with a focus on GnRH-antagonist protocols and when he entered the field in 2002, an intensive debate had just started on the role of GnRH-antagonist based ovarian stimulation in reproductive medicine. His research was key to identifying the optimal usage strategies that continue to be applied worldwide. He also contributed to the early clinical research on GnRH-agonist triggering of final oocyte maturation for OHSS prevention, now also a standard-of-care for patients predicted at increased risk. Beyond reproductive endocrinology, he has a general interest in evidence-based ART practice and the methodological and interpretational challenges when analyzing trial data and observational data, respectively. In Google scholar, 480 publications including textbook chapters and abstracts are listed under his authorship or co-authorship. In addition, he is one of the editors (together with Professor Michael Ludwig and Professor Klaus Diedrich), of the standard textbook on assisted reproduction in the German language.
In a wider professional capacity, Professor Griesinger has long been associated with ESHRE in various functions, first as a junior deputy for the reproductive endocrinology special interest group and then as its coordinator, before going on to serve on the Executive Committee of ESHRE from 2013 to 2017. Other involvements include guideline development groups, both nationally and internationally, resulting in documents such as the ESHRE guideline on ovarian stimulation and the upcoming ESHRE paper on recurrent implantation failure. He is the current national clinical ESHRE representative for Germany. He has also contributed to a number of national initiatives, such as the national guideline on ART practice of the German Medical Association and the establishment of a national quality control system by the German Medical Association which is executed on a federal state level, which he is cross-linking with the ESHRE clinical performance indicator initiative.
His previous editorial appointments include associate editor for Human Reproduction (2008–2012), Fertility and Sterility (2010–2012) and the British Journal of Obstetrics and Gynecology (2013–2016). Currently he is co-editor-in-chief for the German language journal Gynaekologische Endokrinologie (Springer) and editor for Archives of Obstetrics and Gynecology, the organ of the German Society of Obstetrics and Gynecology. Since 2013 he has served as a section editor for RBMO and is now looking forward to continuing that contribution in his new role as an editor. He eloquently describes his motivation as follows. 'It is with the greatest respect that as a section editor, and now an editor for RMBO, I can seek to further contribute to the mission of its founder, Professor Robert Edwards. I have always (and still do) enjoy and learn from peer-reviewing – an arduous task, but very rewarding in many aspects. I am also committed to the idea that publication of scientific methods and data does make a real difference to the lives and families of our patients: this vision has always been truly inspiring and my main motivation. RBMO, which publishes papers across all disciplinary areas relevant to human reproduction, has the potential to boost excellence, innovation, and discovery in our field. Becoming an editor is a challenge, but a good one, and I am excited to have been given the opportunity to play a small role in shaping the future of the journal and our field.'
Published online: January 24, 2023
Publication stageIn Press Journal Pre-Proof
© 2023 Published by Elsevier Ltd on behalf of Reproductive Healthcare Ltd.